Toll-like receptor expression and function in type I bipolar disorder

Brain, Behavior, and Immunity

Volumn 54, Issue , 2016, Pages 110-121

  Wieck, Andrea ^a,c   Grassi Oliveira, Rodrigo ^a   do Prado, Carine Hartmann ^a   Viola, Thiago Wendt ^a   Petersen, Laura Esteves ^a   Porto, Bárbara ^a   Teixeira, Antônio Lúcio ^b   Bauer, Moisés Evandro ^a,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Postgraduate Program in Biomedical Gerontology   (Brazil)

Author keywords

Bipolar disorder; Inflammation; Innate immunity; Monocytes; Regulatory T cells; Toll like receptors

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LITHIUM; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID; CYTOKINE; INTERLEUKIN DERIVATIVE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BIPOLAR I DISORDER; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATORY DISEASE; LYMPHOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BIPOLAR DISORDER; CASE CONTROL STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; MIDDLE AGED; PROCEDURES;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INFLAMMATION; INTERLEUKINS; LIPOPOLYSACCHARIDES; MIDDLE AGED; MONOCYTES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84955441542     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.01.011     Document Type: Article

References (62)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Alcocer-Gomez E., Cordero M.D. NLRP3 inflammasome: a new target in major depressive disorder. CNS Neurosci. Ther. 2014, 20:294-295.
3. Alcocer-Gomez E., de Miguel M., Casas-Barquero N., Nunez-Vasco J., Sanchez-Alcazar J.A., Fernandez-Rodriguez A., Cordero M.D. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav. Immun. 2014, 36:111-117.
4. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
5. Arroyo D.S., Soria J.A., Gaviglio E.A., Rodriguez-Galan M.C., Iribarren P. Toll-like receptors are key players in neurodegeneration. Int. Immunopharmacol. 2011, 11:1415-1421.
6. Bagwell C.B. Hyperlog-a flexible log-like transform for negative, zero, and positive valued data. Cytometry A 2005, 64:34-42.
7. Barbosa I.G., Bauer M.E., Machado-Vieira R., Teixeira A.L. Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast. 2014, 2014:360481.
8. Barbosa I.G., Nogueira C.R., Rocha N.P., Queiroz A.L., Vago J.P., Tavares L.P., Assis F., Fagundes C.T., Huguet R.B., Bauer M.E., Teixeira A.L., de Sousa L.P. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients. J. Psychiatr. Res. 2013, 47:1949-1954.
9. Botos I., Segal D.M., Davies D.R. The structural biology of toll-like receptors. Structure 2011, 19:447-459.
10. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003, 197:403-411.
11. Carty M., Bowie A.G. Evaluating the role of toll-like receptors in diseases of the central nervous system. Biochem. Pharmacol. 2011, 81:825-837.
12. Collins S.M., Surette M., Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 2012, 10:735-742.
13. Crellin N.K., Garcia R.V., Hadisfar O., Allan S.E., Steiner T.S., Levings M.K. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 2005, 175:8051-8059.
14. Crews F.T., Qin L., Sheedy D., Vetreno R.P., Zou J. High mobility group box 1/toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence. Biol. Psychiatry 2013, 73:602-612.
15. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13:701-712.
16. Cryan J.F., Dinan T.G. More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology: official publication of the American College of. Neuropsychopharmacology 2015, 40:241-242.
17. Dinan T.G., Cryan J.F. The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr. Opin. Clin. Nutr. Metab. Care 2015, 18:552-558.
18. do Prado C.H., Rizzo L.B., Wieck A., Lopes R.P., Teixeira A.L., Grassi-Oliveira R., Bauer M.E. Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology 2013, 38:667-676.
19. El Aidy S., Dinan T.G., Cryan J.F. Immune modulation of the brain-gut-microbe axis. Front. Microbiol. 2014, 5:146.
20. Evrensel A., Ceylan M.E. The gut-brain axis: the missing link in depression. Clin. Psychopharmacol. Neurosci. 2015, 13:239-244.
21. Fang P., Schachner M., Shen Y.Q. HMGB1 in development and diseases of the central nervous system. Mol. Neurobiol. 2012, 45:499-506.
22. Foster J.A., McVey Neufeld K.A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013, 36:305-312.
23. Frank M.G., Weber M.D., Watkins L.R., Maier S.F. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun. 2015, 48:1-7.
24. Hayward J.H., Lee S.J. A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases. Exp. Neurobiol. 2014, 23:138-147.
25. Heine H., Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 2003, 130:180-192.
26. Hong J., Cho I.H., Kwak K.I., Suh E.C., Seo J., Min H.J., Choi S.Y., Kim C.H., Park S.H., Jo E.K., Lee S., Lee K.E., Lee S.J. Microglial toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J. Biol. Chem. 2010, 285:39447-39457.
27. Hung Y.Y., Kang H.Y., Huang K.W., Huang T.L. Association between toll-like receptors expression and major depressive disorder. Psychiatry Res. 2014, 220:283-286.
28. Ishii K.J., Coban C., Akira S. Manifold mechanisms of toll-like receptor-ligand recognition. J. Clin. Immunol. 2005, 25:511-521.
29. Juster R.P., McEwen B.S., Lupien S.J. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci. Biobehav. Rev. 2010, 35:2-16.
30. Kapczinski F., Vieta E., Andreazza A.C., Frey B.N., Gomes F.A., Tramontina J., Kauer-Sant'anna M., Grassi-Oliveira R., Post R.M. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008, 32:675-692.
31. Kawai T., Akira S. TLR signaling. Cell Death Differ. 2006, 13:816-825.
32. Kawasaki T., Kawai T. Toll-like receptor signaling pathways. Front. Immunol. 2014, 5:461.
33. Kéri S., Szabó C., Kelemen O. Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behav. Immun. 2014, 40:235-243.
34. Kim H.K., Chen W., Andreazza A.C. The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder. Neural Plast. 2015, 2015:408136.
35. Laflamme N., Echchannaoui H., Landmann R., Rivest S. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur. J. Immunol. 2003, 33:1127-1138.
36. Laflamme N., Soucy G., Rivest S. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding toll-like receptor 2 in the CNS. J. Neurochem. 2001, 79:648-657.
37. Liu G., Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 2007, 122:149-156.
38. Liu H., Komai-Koma M., Xu D., Liew F.Y. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7048-7053.
39. Liu J., Buisman-Pijlman F., Hutchinson M.R. Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front. Neurosci. 2014, 8:309.
40. Louveau A., Smirnov I., Keyes T.J., Eccles J.D., Rouhani S.J., Peske J.D., Derecki N.C., Castle D., Mandell J.W., Lee K.S., Harris T.H., Kipnis J. Structural and functional features of central nervous system lymphatic vessels. Nature 2015, 523:337-341.
41. Mazzoni A., Segal D.M. Controlling the toll road to dendritic cell polarization. J. Leukoc. Biol. 2004, 75:721-730.
42. McKernan D.P., Dennison U., Gaszner G., Cryan J.F., Dinan T.G. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl. Psychiatry 2011, 1:e36.
43. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
44. Modabbernia A., Taslimi S., Brietzke E., Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 2013, 74:15-25.
45. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34:269-281.
46. Oliveira J., Busson M., Etain B., Jamain S., Hamdani N., Boukouaci W., Amokrane K., Bennabi M., Le Guen E., Dargél A.A., Houenou J., Ivanova R., Bellivier F., Henry C., Kahn J.P., Charron D., Krishnamoorthy R., Vervoitte L., Leboyer M., Tamouza R. Polymorphism of toll-like receptor 4 gene in bipolar disorder. J. Affect. Disord. 2014, 152-154:395-402.
47. Oliveira J., Etain B., Lajnef M., Hamdani N., Bennabi M., Bengoufa D., Sundaresh A., Chaabane A.B., Bellivier F., Henry C., Kahn J.P., Charron D., Krishnamoorthy R., Leboyer M., Tamouza R. Combined effect of TLR2 gene polymorphism and early life stress on the age at onset of bipolar disorders. PLoS One 2015, 10:e0119702.
48. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
49. Qian C., Cao X. Regulation of toll-like receptor signaling pathways in innate immune responses. Ann. N. Y. Acad. Sci. 2013, 1283:67-74.
50. Qian F., Wang X., Zhang L., Chen S., Piecychna M., Allore H., Bockenstedt L., Malawista S., Bucala R., Shaw A.C., Fikrig E., Montgomery R.R. Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 2012, 11:104-110.
51. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
52. Rogier R., Koenders M.I., Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J. Immunol. Res. 2015, 2015:527696.
53. Rook G.A., Raison C.L., Lowry C.A. Microbiota, immunoregulatory old friends and psychiatric disorders. Adv. Exp. Med. Biol. 2014, 817:319-356.
54. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
55. Sutmuller R., Garritsen A., Adema G.J. Regulatory T cells and toll-like receptors: regulating the regulators. Ann. Rheum. Dis. 2007, 66(Suppl. 3):iii91-iii95.
56. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., Kullberg B.J., Joosten L.A., Akira S., Netea M.G., Adema G.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Investig. 2006, 116:485-494.
57. Sutmuller R.P., Morgan M.E., Netea M.G., Grauer O., Adema G.J. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 2006, 27:387-393.
58. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13798-13803.
59. Wieck A., Grassi-Oliveira R., do Prado C.H., Rizzo L.B., de Oliveira A.S., Kommers-Molina J., Viola T.W., Teixeira A.L., Bauer M.E. Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder. Brain Behav. Immun. 2013, 34:47-55.
60. Wu T.Y., Liu L., Zhang W., Zhang Y., Liu Y.Z., Shen X.L., Gong H., Yang Y.Y., Bi X.Y., Jiang C.L., Wang Y.X. High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior. J. Psychiatr. Res. 2015, 64:99-106.
61. Yu M., Wang H., Ding A., Golenbock D.T., Latz E., Czura C.J., Fenton M.J., Tracey K.J., Yang H. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006, 26:174-179.
62. Zanin-Zhorov A., Cahalon L., Tal G., Margalit R., Lider O., Cohen I.R. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J. Clin. Investig. 2006, 116:2022-2032.